The effects of type 1 diabetes and its long-term complications on physical and mental health status

PharmacoEconomics

Volumn 24, Issue 6, 2006, Pages 559-569

  Hahl, Jarmo ^a,b   Hämäläinen, Helena ^c   Simell, Tuula ^d   Simell, Olli ^d  

^a UNIVERSITY OF TURKU   (Finland)

^b GLAXOSMITHKLINE   (Finland)

^c SOCIAL INSURANCE INSTITUTION   (Finland)

^d UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FINLAND; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REGRESSION ANALYSIS; REIMBURSEMENT;

ADULT; AGE FACTORS; AGED; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; FEMALE; FINLAND; HEALTH STATUS; HUMANS; MALE; MENTAL HEALTH; MIDDLE AGED; QUESTIONNAIRES; REGISTRIES;

EID: 33745113800     PISSN: 11707690     EISSN: 11707690     Source Type: Journal    
DOI: 10.2165/00019053-200624060-00004     Document Type: Article

References (54)

1. Podar T, Solntsev A, Karvonen M, et al. Increasing incidence of childhood-onset type I diabetes in 3 Baltic countries and Finland 1983-1998. Diabetologia 2001; 44 Suppl. 3: B17-20
2. Onkamo P, Väänänen S, Karvonen M, et al. Worldwide increase in incidence of type I diabetes: the analysis of the data on published incidence trends. Diabetologia 1999; 42: 1395-403
3. Simell TT, Sintonen H, Hahl J, et al. Costs of insulin-dependent diabetes mellitus. Pharmacoeconomics 1996; 9: 24-38
4. Lounamaa R. Mortality in Finnish patients with insulin-dependent diabetes mellitus: a follow-up study of patients diagnosed when under twenty years of age. ML: 126. Helsinki: Social Insurance Institution, 1993
5. Borch-Johnsen K, Kreiner S, Deckert T. Mortality of type 1 (insulin-dependent) diabetes mellitus in Denmark: a study of relative mortality in 2930 Danish type 1 diabetic patients diagnosed from 1933 to 1972. Diabetologia 1986; 29: 767-72
6. Dorman JS, LaPorte RE, Kuller LH, et al. The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study. Diabetes 1984; 33: 271-6
7. Green A, Borch-Johnsen K, Andersen KP, et al. Relative mortality of type 1 (insulin-dependent) diabetes in Denmark: 1933-1981. Diabetologia 1985; 28: 339-42
8. Hart HE, Bilo HJG, Redekop WK, et al. Quality of life of patients with type I diabetes mellitus. Qual Life Res 2003; 12: 1089-97
9. Tabaei BP, Shill-Novak J, Brandle M, et al. Glycemia and the quality of well-being in patients with diabetes. Qual Life Res 2004; 13: 1153-61
10. Hahl J, Hämäläinen H, Sintonen H, et al. Health-related quality of life in type 1 diabetes without or with symptoms of long-term complications. Qual Life Res 2002; 11: 427-36
11. Nordfeldt S, Jonsson D. Short-term effects of severe hypoglycaemia in children and adolescents with type 1 diabetes: a cost-of-illness study. Acta Paediatr 2001; 90: 137-42
12. Sureshkumar KK, Mubin T, Mikhael N, et al. Assessment of quality of life after simultaneous pancreas-kidney transplantation. Am J Kidney Dis 2002; 39: 1300-6
13. Fryback DG, Lawrence WF, Martin PA, et al. Predicting quality of well-being scores from the SF-36: results from the Beaver Dam Health Outcomes Study. Med Decis Making 1997; 17: 1-9
14. Taylor MD, Frier BM, Gold AE, et al. Psychosocial factors and diabetes-related outcomes following diagnosis of type 1 diabetes in adults: The Edinburgh Prospective Diabetes Study. Diabet Med 2003; 20: 135-46
15. Linkeschova R, Raoul M, Bott U, et al. Less severe hypoglychosocial caemia, better metabolic control, and improved quality of life in type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy: an observational study of 100 consecutive patients followed for a mean of 2 years. Diabet Med 2002; 19: 746-51
16. Bruttomesso D, Pianta A, Crazzolara D, et al. Continuous subcutaneous insulin infusion (CSII) in the Veneto region: efficacy, acceptability and quality of life. Diabet Med 2002; 19: 628-34
17. The DAFNE study group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ 2002; 325: 746-51
18. Weinger K, Jacobson AM. Psychosocial and quality of life correlates of glycemic control during intensive treatment of type 1 diabetes. Patient Educ Couns 2001; 42: 123-31
19. Hoey H, Aanstoot H-J, Chiarelli F, et al. Good metabolic control is associated with better quality of life in 2101 adolescents with type 1 diabetes. Diabetes Care 2001; 24: 1923-8
20. Tamas G, Marre M, Astorga R, et al. Glycaemic control in type 1 diabetic patients using optimised insulin aspart or human insulin in a randomised multinational study. Diabetes Res Clin Pract 2001; 54: 105-14
21. Cox DJ, Gonder-Frederick L, Polonsky W, et al. Blood glucose awareness training (BGAT-2): long-term benefits. Diabetes Care 2001; 24: 637-42
22. Gross CR, Limwattananon C, Matthees B, et al. Impact of transplantation on quality of life in patients with diabetes and renal dysfunction. Transplantation 2000; 70: 1736-46
23. Lloyd CE, Orchard TJ. Physical and psychological well-being in adults with type 1 diabetes. Diabetes Res Clin Pract 1999; 44: 9-19
24. Epidemiology of diabetes interventions and complications (EDIC): design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group. Diabetes Care 1999; 22: 99-111
25. Hermann BP, Vickrey B, Hays J, et al. A comparison of health-related quality of life in patients with epilepsy, diabetes and multiple sclerosis. Epilepsy Res 1996; 25: 113-8
26. Keinänen-Kiukaanniemi S, Ohinmaa A, Pajunpääa P, et al. Health related quality of life in diabetic patients measured by the Nottingham Health Profile. Diabet Med 1995; 13: 382-8
27. Klein BEK, Klein R, Moss SE. Self-rated health and diabetes of long duration. Diabetes Care 1998; 21: 236-40
28. Influence of intensive diabetes treatment on quality-of-life outcomes in the diabetes control and complications trial: the Diabetes Control and Complications Trial Research Group. Diabetes Care 1996; 19: 195-203
29. Wu S-Y, Sainfort F, Tomar RH, et al. Development and application of a model to estimate the impact of type 1 diabetes on health-related quality of life. Diabetes Care 1998; 21: 725-31
30. Wikblad K, Leksell J, Wibell L. Health-related quality of life in relation to metabolic control and late complications in patients with insulin dependent diabetes mellitus. Qual Life Res 1996; 5: 123-30
31. Ẅandell PE, Brorsson B, Åberg H. Quality of life in diabetic patients registered with primary health care services in Sweden. Scand J Prim Health Care 1997; 15: 97-102
32. Aalto A-M, Uutela A, Aro AR. Health related quality of life among insulin-dependent diabetics: disease-related and psychosocial correlates. Patient Educ Couns 1997; 30: 215-25
33. Jacobson AM, de Groot M, Samson JA. The effects of psychiatric disorders and symptoms on quality of life in patients with type I and type II diabetes mellitus. Qual Life Res 1997; 6: 11-20
34. Kohen D, Burgess AP, Catalan J, et al. The role of anxiety and depression in quality of life and symptom reporting in people with diabetes mellitus. Qual Life Res 1998; 7: 197-204
35. Piehlmeier W, Bullinger M, Kirchberger I, et al. Evaluation of the quality of life of patients with insulin-dependent diabetes mellitus before and after organ transplantation with the SF 36 health survey. Eur J Surg 1996; 162: 933-40
36. Kiebert GM, van Oosterhout EC, van Bronswijk H, et al. Quality of life after combined kidney-pancreas or kidney transplantation in diabetic patients with end-stage renal disease. Clin Trasplant 1994; 8: 239-45
37. Bott U, Mühlhauser I, Overmann H, et al. Validation of a diabetes-specific quality-of-life scale for patients with type 1 diabetes. Diabetes Care 1998; 21: 757-69
38. Bradley C, Todd C, Gorton T, et al. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual Life Res 1999; 8: 79-91
39. Hammond GS, Aoki TT. Measurement of health status in diabetic patients: diabetes impact measurement scales. Diabetes Care 1992; 15: 469-77
40. Jacobson AM, de Groot M, Samson JA. The evaluation of two measures of quality of life in patients with type I and type II diabetes. Diabetes Care 1994; 17: 267-74
41. Kotsanos JG, Vignati L, Huster W, et al. Health-related quality-of-life results from multinational clinical trials of insulin lispro: assessing benefits of a new diabetes therapy. Diabetes Care 1997; 20: 948-58
42. Meadows K, Steen N, McColl E, et al. The Diabetes Health Profile (DHP): a new instrument for assessing the psychosocial profile of insulin-requiring patients. Development and psychometric evaluation. Qual Life Res 1996; 5: 242-54
43. Boyer JG, Earp JA. The development of an instrument for assessing the quality of life of people with diabetes. Med Care 1997; 35: 440-53
44. Garrat AM, Schmidt L, Fitzpatrick R. Patient-assessed health outcome measures for diabetes: a structured review. Diabet Med 2002; 19: 1-11
45. Brazier J. The SF-36 health survey questionnaire: a tool for economists. Health Econ 1993; 2 (3): 213-5
46. Bradley C. Measuring quality of life in diabetes. In: Marshall SM, Home PD, Rizza RA, editors. The diabetes annual/10. Amsterdam: Elsevier Science BV, 1996: 207-24
47. Aalto A-M, Aro AR, Teperi J. RAND-36 as a measure of health-related quality of life: reliability, construct validity and reference values in the Finnish general population [in Finnish with English summary]. Helsinki: Stakes, Research Reports 101, 1999
48. Hays RD, Sherbourne CD, Mazel R. The RAND 36-item Health Survey 1.0. Health Econ 1993; 2: 217-27
49. Alonso J, Ferrer M, Gandek B, et al. Health-related quality of life associated with chronic conditions in eight countries: results from the International Quality of Life Assessment (IQOLA) project. Qual Life Res 2004; 13: 283-98
50. Cunningham WE, Nakazono TT, Tsai KL, et al. Do differences in methods for constructing SF-36 physical and mental health summary measures change their association with chronic medical conditions and utilization? Qual Life Res 2003; 12: 1029-35
51. Samsa G, Edelman D, Rothman ML, et al. Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics 1999; 15: 141-55
52. Ware JE, Kosinski M, Bayliss MS, et al. Comparison of methoods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care 1995; 33: AS264-79
53. SPSS Inc. SPSS Base 9.0 users guide. Chicago: SPSS Inc., 1999
54. Hair JF Jr, Anderson RE, Tatham RL, et al. Multivariate data analysis with readings. Englewood Cliffs (NJ): Prentice-Hall, 2001